- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 636431 [Title] => Hearty news from MSD [Summary] =>A new investigational study of Ezetimibe/Simvastatin, the cholesterol-lowering medicine from MSD (known as Merck in US and Canada) showed that at dosage of 10/20 mg, it reduced the incidence of first major vascular events defined as non-fatal heart attacks or cardiac death, stroke or any revascularization procedure by a highly statistically significant 16.1 percent compared to placebo (p=0.0010).
[DatePublished] => 2010-12-07 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
RENAL WEEK
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 636431 [Title] => Hearty news from MSD [Summary] =>A new investigational study of Ezetimibe/Simvastatin, the cholesterol-lowering medicine from MSD (known as Merck in US and Canada) showed that at dosage of 10/20 mg, it reduced the incidence of first major vascular events defined as non-fatal heart attacks or cardiac death, stroke or any revascularization procedure by a highly statistically significant 16.1 percent compared to placebo (p=0.0010).
[DatePublished] => 2010-12-07 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
abtest
EZ2 - 28 2
SUERTRES - 6 1 9
6/49 Lotto - 16 22 13 28 9 27
P15,840,000.00
6/58 Ultra Lotto - 31 56 15 51 30 14
P150,367,501.00
- 12:00 am